Author

Mina Kang

New York University Abu Dhabi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Ashish Kumar JaiswaliD· 1 shared Bushra DohaiiD· 1 shared Christophe PouletiD· 1 shared David R. Nelson· 1 shared Diana Charles El AssaliD· 1 shared Jean‐Claude TwizereiD· 1 shared Kourosh Salehi‐AshtianiiD· 1 shared Pascal Falter‐BrauniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Ashish Kumar JaiswalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Conserved metabolic vulnerabilities across pathogenic coronaviruses nominate host-directed therapeutic targets

Bushra Dohai, Diana Charles El Assal, Mina Kang, Ashish Kumar Jaiswal, Christophe Poulet, Sarah Daakour, David R. Nelson, Pascal Falter‐Braun, Jean‐Claude Twizere, Kourosh Salehi‐Ashtiani

The paper identifies conserved metabolic vulnerabilities across SARS-CoV, SARS-CoV-2, and MERS-CoV using transcriptomic data and metabolic models, revealing druggable host targets.

bioRxiv · Apr 20, 2026 · PreprintSystems Biology